Skip to content
Screener

Boston Scientific BSX Short-term debt and current portion of long-term debt

Short-term debt and current portion of long-term debt at other companies

TFX
TeleflexTFX
$87.5M-12.5%
Stryker logo
StrykerSYK
$499M-79.2%
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$71.45B-53.2%
P/E19.5×-41.6×
P/S3.4×-4.8×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 6:25 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885725-26-000033
(in millions, except share and per share data)As of / March 31, 2026As of / December 31, 2025
TOTAL ASSETS$44,351$43,673
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current debt obligations$41$299
Accounts payable1,1411,144
Accrued expenses2,5143,201
Other current liabilities875795
Total current liabilities4,5715,439

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Boston Scientific's short-term debt and current portion of long-term debt?
Boston Scientific (BSX) reported short-term debt and current portion of long-term debt of $41M in Q1 2026.
How has Boston Scientific's short-term debt and current portion of long-term debt changed year-over-year?
Boston Scientific's short-term debt and current portion of long-term debt decreased by 94.7% year-over-year, from $777M to $41M.
What is the long-term trend for Boston Scientific's short-term debt and current portion of long-term debt?
Over 5 years (2020 to 2025), Boston Scientific's short-term debt and current portion of long-term debt has grown at a 87.2% compound annual growth rate (CAGR), from $13M to $299M.
What does short-term debt and current portion of long-term debt mean?
This represents the portion of debt obligations and lease liabilities that are due for repayment within the next twelve months. It is a critical component of liquidity analysis, indicating the immediate cash requirements to service debt. High levels relative to cash flow can signal potential refinancing risks.

Ask your AI about Boston Scientific's short-term debt and current portion of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude